Specific alterations of regional myocardial work in strength-trained athletes using anabolic androgenic steroids compared to athletes with genetic hypertrophic cardiomyopathy

• Үндсэн зохиолчид: Antoine Grandperrin (Зохиогч), Frédéric Schnell (Зохиогч), Erwan Donal (Зохиогч), Elena Galli (Зохиогч), Christophe Hedon (Зохиогч), Olivier Cazorla (Зохиогч), Stéphane Nottin (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Elsevier, 2023-07-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Background: Strength-trained athletes using anabolic androgenic steroids (AAS) have left ventricular (LV) hypertrophy and myocardial fibrosis that can lead to sudden cardiac death. A similar feature was described in athletes with hypertrophic cardiomyopathy (HCM), which complicates the diagnosis for...